As of 2025-07-04, the EV/EBITDA ratio of Iaso Private General Obstetric Gynecological & Paediatrics Clinic Diagnostic Therapeutic & Research Center SA (IASO.AT) is 10. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IASO.AT's latest enterprise value is 225 mil EUR. IASO.AT's TTM EBITDA according to its financial statements is 22 mil EUR. Dividing these 2 quantities gives us the above IASO.AT EV/EBITDA ratio.
Range | Selected | |
Trailing EV/EBITDA multiples | 5.7x - 8.9x | 7.5x |
Forward EV/EBITDA multiples | 6.9x - 9.1x | 8x |
Fair Price | 0.7 - 1.29 | 0.96 |
Upside | -53.1% - -13.8% | -35.8% |
(EUR in millions except Fair Price) | |||
Trailing | Forward | ||
Market Cap (EUR mil) | EV/EBITDA | EV/EBITDA | |
Iaso Private General Obstetric Gynecological & Paediatrics Clinic Diagnostic Therapeutic & Research Center SA | 183 | 10x | 11.9x |
Clinica Baviera SA | 703 | 3.1x | 8.4x |
EMC Instytut Medyczny SA | 111 | 8.7x | 7.5x |
Ramsay Generale de Sante SA | 1,220 | 1.6x | 14.3x |
Latvijas Juras Medicinas Centrs AS | 5 | 6.3x | 3.2x |
Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS | 10 | 11.3x | 6.1x |
M1 Kliniken AG | 293 | 9.2x | 10.1x |
Maternus Kliniken AG | 29 | 30.6x | 30.6x |
MD Medical Group Investments PLC | 451 | 4.8x | 4.4x |
Totally PLC | 1 | 1.7x | 1.7x |
Industry median | 7.5x | 8x | |
(*) EBITDA | 22 | 19 | |
Enterprise value | 168 | 151 | |
(-) Net debt | 42 | 42 | |
Equity value | 126 | 109 | |
(/) Outstanding shares | 122 | 122 | |
Fair price | 1 | 1 | |